Cdk1/cyclin B, active

C-terminal 6His-tagged recombinant, human full length cdk1, and N-terminal GST-tagged human full length cyclin B.

Catalog #: 14-450


Biological Information
Background Information:
The cyclin-dependent kinases (CDKs), a subfamily of protein kinases, promote cell cycle progression. In mammals, nine different CDKs (cdk 1 to cdk 9; cdk 1 is better known as cdc 2) have been identified. CDKs are regulated on various levels including binding of proteins (cyclins, inhibitors, and assembly factors), protein degradation, transcriptional control, localization, and multiple phosphorylations. This leads to timely regulation of CDK activity, allowing progression from one cell cycle phase to the next. The cdk1 induces entry into M-phase of the cell cycle in eukaryotes. GenBank NM_001786 / EMBL M25753
Target Class:
Serine/Threonine Kinase: CDK1 subfamily
Accession Number:
NM_001786.2; NM_033379.2
Target Name:
Target Aliases:
CDC2, CDK1, MGC111195, DKFZp686L20222, CDC28A
Target Species:
Product Type:
Drug Discovery & Development
Storage Conditions:
6 months at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit for a list of products that are governed by limited use label license terms and relevant patent and trademark information.


14-450x Datasheet

View Document